State Street’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

State Street’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-228,121	Closed	-$274K	–	4463
2023 Q4	$274K	Hold	228,121	–	–	﹤0.01%	3809
2023 Q3	$197K	Buy	228,121 +3,550	+2%	+$3.89K	﹤0.01%	3947
2023 Q2	$269K	Buy	224,571 +169,508	+308%	+$848K	﹤0.01%	3915
2023 Q1	$481K	Buy	55,063 +24,100	+78%	+$223K	﹤0.01%	3756
2022 Q4	$248K	Buy	30,963 +7,505	+32%	+$47.1K	﹤0.01%	4022
2022 Q3	$114K	Hold	23,458	–	–	﹤0.01%	4420
2022 Q2	$130K	Sell	23,458 -168,343	-88%	-$578K	﹤0.01%	4400
2022 Q1	$972K	Buy	191,801 +56,723	+42%	+$455K	﹤0.01%	3825
2021 Q4	$1.74M	Buy	135,078 +22,537	+20%	+$322K	﹤0.01%	3679
2021 Q3	$1.68M	Buy	112,541 +23,406	+26%	+$399K	﹤0.01%	3656
2021 Q2	$1.39M	Buy	+89,135	New	+$1.56M	﹤0.01%	3610

State Street's RAIN Position: Q1 2024 in Review

State Street sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 228,121 shares — an estimated $274K sold.

State Street first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $1.74M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

State Street reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 228,121 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $274K.
State Street first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
State Street's Rain Oncology Inc. Common Stock position peaked at $1.74M in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.